Enzon Pharmaceuticals Analysis

Enzon OTC Stock Analysis Notes

About 49.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.04. Enzon Pharmaceuticals last dividend was issued on the 30th of September 2019. The entity had 1:1 split on the 29th of September 2017. Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company was founded in 1981 and is headquartered in Cranford, New Jersey. Enzon Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Enzon Pharmaceuticals is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about Enzon Pharmaceuticals call the company at 732 980 4500 or check out https://www.enzon.com.

Enzon Pharmaceuticals Investment Alerts

Enzon Pharmaceuticals Upcoming and Recent Events

Enzon Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 19.72 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Enzon Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Enzon Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Enzon Pharmaceuticals Outstanding Bonds

Enzon Pharmaceuticals Predictive Daily Indicators

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Enzon Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Enzon shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Enzon Pharmaceuticals. By using and applying Enzon OTC Stock analysis, traders can create a robust methodology for identifying Enzon entry and exit points for their positions.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Enzon Pharmaceuticals information on this page should be used as a complementary analysis to other Enzon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

If you are still planning to invest in Enzon Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzon Pharmaceuticals' history and understand the potential risks before investing.